Skip to main content
OpenTrials

Clinical trial condition

Ovarian Cancer

Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1,443 public trials 326 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Cancer trial results

Completed

Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors

NCT00003518

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +19 more
Locations
  • CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • Veterans Affairs Medical Center - Chicago (Lakeside) Chicago, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
View all 19 locations
View Trial Details
Completed

A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

NCT04440943

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +61 more
Locations
  • Northside Hospital Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
  • Duke Cancer Center Durham, North Carolina, United States
View Trial Details
Completed

An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors

NCT01618136

Conditions
Adnexal Diseases, Advanced Melanoma, B-cell Malignancy, Low-grade, +37 more
Locations
  • King's College London Guy's Hospital Campus London, United Kingdom
  • Newcastle Upon Tyne NHS Foundation Trust Newcastle Upon Tyne and Wear, United Kingdom
View Trial Details
Completed

A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

NCT01891344

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +26 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Saint Jude Heritage Medical Center Fullerton, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 75 locations
View Trial Details
Completed

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

NCT02855944

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +26 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Augusta University Augusta, Georgia, United States
  • Hospital Haroldo Juacaba Instituto do Cancer do Ceara Fortaleza, Ceará, Brazil
  • Instituto de Oncologia do Parana (IOP) Curitiba, Paraná, Brazil
View all 77 locations
View Trial Details
Completed

A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)

NCT01482715

Conditions
Adnexal Diseases, Advanced Solid Tumor With Evidence of Germline or Somatic BRCA, Disease Attributes, +22 more
Locations
  • UCSF San Francisco, California, United States
  • Sarah Cannon Research Institute Sarasota, Florida, United States
  • Dana-Farber Cancer Institute (Part 3 only) Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 16 locations
View Trial Details
Completed

Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

NCT01968213

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Saint Jude Heritage Medical Center Fullerton, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 96 locations
View Trial Details

Related conditions